Medinno
PrivateLast Round
Strategic
Sep 8, 2025
Total Funding Raised
$9.94M
Momentum Score
50 /100
Company Overview
Medinno is a biotechnology company that develops cell therapeutics for degenerative and neonatal brain diseases such as stroke, Alzheimer's, Hypoxic-Ischemic Encephalopathy (HIE), and Intraventricular Hemorrhage (IVH).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medinno Comps
Public and private peers based on sector, stage, and business model.
Medinno Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 8, 2025 | ||||
| Series C | Oct 17, 2023 | ||||
| Seed | Jul 1, 2018 |
Key People
Founding team and executive leadership
Medinno Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series C |
| CKD Venture Capital | Series C |
| CJ Investment | Series C |
| Mint Venture Partners | Series C |
| Xinchang County People's Government | Strategic |
| Partners Investment | Seed |
| T Investment | Series C |
Medinno Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medinno's valuation, stock price, and market status.